- Home
- Publications
- Publication Search
- Publication Details
Title
Angiogenesis inhibitors in the treatment of prostate cancer
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 11, Issue 2, Pages 233-247
Publisher
Informa Healthcare
Online
2010-01-21
DOI
10.1517/14656560903451716
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Presurgical sunitinib malate and androgen ablation in patients with localized prostate cancer at high risk for recurrence
- (2017) A. J. Zurita et al. JOURNAL OF CLINICAL ONCOLOGY
- A modular phase I study of lenalidomide and paclitaxel in metastatic castration-resistant prostate cancer with prior taxane therapy
- (2017) L. C. Pagliaro et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 1 study of weekly anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody IMC-18F1 in patients with advanced solid malignancies
- (2017) S. S. Krishnamurthi et al. JOURNAL OF CLINICAL ONCOLOGY
- Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer
- (2009) Jeanny B. Aragon-Ching et al. BJU INTERNATIONAL
- Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer
- (2009) A. Fontana et al. CLINICAL CANCER RESEARCH
- Aflibercept (AVE0005): an alternative strategy for inhibiting tumour angiogenesis by vascular endothelial growth factors
- (2009) Quincy Siu-Chung Chu EXPERT OPINION ON BIOLOGICAL THERAPY
- Vandetanib Versus Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study
- (2009) Ronald B. Natale et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Oral Lenalidomide in Patients With Refractory Metastatic Cancer
- (2009) William L. Dahut et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A Double-Blind Randomized Crossover Study of Oral Thalidomide Versus Placebo for Androgen Dependent Prostate Cancer Treated With Intermittent Androgen Ablation
- (2009) William D. Figg et al. JOURNAL OF UROLOGY
- About sorafenib in castration-resistant prostate cancer
- (2008) G. Colloca et al. ANNALS OF ONCOLOGY
- Circulating endothelial cells as a therapeutic marker for thalidomide in combined therapy with chemotherapy drugs in a human prostate cancer model
- (2008) Haiqing Li et al. BJU INTERNATIONAL
- Hypoxia in prostate cancer: A powerful shield against tumour destruction?
- (2008) L. Marignol et al. CANCER TREATMENT REVIEWS
- A Phase II Clinical Trial of Sorafenib in Androgen-Independent Prostate Cancer
- (2008) W. L. Dahut et al. CLINICAL CANCER RESEARCH
- Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 Study
- (2008) Giuseppe Di Lorenzo et al. EUROPEAN UROLOGY
- Lenalidomide: a novel anticancer drug with multiple modalities
- (2008) Christine Galustian et al. EXPERT OPINION ON PHARMACOTHERAPY
- Thalidomide: Mechanisms of Action
- (2008) Taraneh Paravar et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- In vivo and in vitro effects of a HIF-1α inhibitor, RX-0047
- (2008) Z. Gunnur Dikmen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- (2008) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Examining the acute effects of cediranib (RECENTIN, AZD2171) treatment in tumor models: a dynamic contrast-enhanced MRI study using gadopentate
- (2008) Daniel P. Bradley et al. MAGNETIC RESONANCE IMAGING
- Phase 2 study of granulocyte-macrophage colony-stimulating factor plus thalidomide in patients with hormone-naïve adenocarcinoma of the prostate
- (2008) Robert J. Amato et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia
- (2007) Agustin A. Garcia et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started